Faron Pharmaceuticals Oy (AIM:FARN)
London · Delayed Price · Currency is GBP · Price in GBX 39.00
+3.50 (9.86%)
Sep 25, 2026, 10:38 AM GMT
Faron Pharmaceuticals Oy Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
36
Market Cap
73.32M GBP
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | - | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Bioventix | 12.54M |
| IXICO | 7.28M |
| PureTech Health | 4.80M |
| Scancell Holdings | 4.71M |
| Arecor Therapeutics | 1.71M |
| 4basebio | 1.69M |
| Ondine Biomedical | 1.43M |
| ImmuPharma | -69.96K |
Faron Pharmaceuticals Oy News
- 4 weeks ago - Faron Pharmaceuticals Oy Earnings Call Transcript: H1 2026 - Transcripts
- 4 weeks ago - Faron Pharmaceuticals Oy Quarterly report: H1 2026 - Filings
- 4 weeks ago - Faron Pharmaceuticals Oy Slides: H1 2026 - Filings
- 6 weeks ago - Faron Pharmaceuticals share price targets 762% on bexmarilimab trial momentum - ABC Money
- 3 months ago - Faron Pharmaceuticals Oy Transcript: Status update - Transcripts
- 3 months ago - Faron Pharmaceuticals Oy Press release: Status update - Filings
- 6 months ago - Faron Pharmaceuticals Oy Transcript: Investor update - Transcripts
- 6 months ago - Faron Pharmaceuticals Oy Slides: Investor update - Filings